Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Clin Ter ; 164(5): e413-28, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24217844

RESUMO

The development of the biological drugs has revolutionized the therapeutic approach of the chronic inflammatory rheumatic diseases, particularly in patients resistant to standard treatment. These drugs are characterized by an innovative mechanism of action, based on the targeted inhibition of specific molecular or cellular targets directly involved in the pathogenesis of the diseases: pro-inflammatory cytokines (tumor necrosis factor, interleukin-1 and 6), CTLA-4, and molecules involved in the activation, differentiation and maturation of B cells. Their use has indeed allowed for a better prognosis in several rheumatic diseases (such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus) and to obtain a clinical remission. In the present review we give an overview of the biological drugs currently available for the treatment of the rheumatic diseases, analyzing the different mechanism of action, the therapeutic indications and efficacy data, and adverse events.


Assuntos
Terapia Biológica , Doenças Reumáticas/terapia , Abatacepte , Anticorpos Monoclonais/efeitos adversos , Anticorpos Monoclonais/imunologia , Anticorpos Monoclonais/uso terapêutico , Anticorpos Monoclonais Murinos/uso terapêutico , Subpopulações de Linfócitos B/imunologia , Terapia Biológica/efeitos adversos , Terapia Biológica/estatística & dados numéricos , Terapia Biológica/tendências , Quimioterapia Combinada , Humanos , Imunoconjugados/imunologia , Imunoconjugados/uso terapêutico , Imunoglobulina G/imunologia , Imunoglobulina G/uso terapêutico , Imunossupressores/administração & dosagem , Imunossupressores/uso terapêutico , Interferons/antagonistas & inibidores , Interleucina-1/antagonistas & inibidores , Interleucina-6/antagonistas & inibidores , Depleção Linfocítica , Estudos Multicêntricos como Assunto , Uso Off-Label , Ensaios Clínicos Controlados Aleatórios como Assunto , Receptores Tipo II do Fator de Necrose Tumoral/antagonistas & inibidores , Rituximab , Fator de Necrose Tumoral alfa/antagonistas & inibidores
2.
Clin Exp Rheumatol ; 28(2): 250-3, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20483048

RESUMO

OBJECTIVES: Osteoarthritis (OA) is a chronic rheumatic disease characterized by progressive cartilage destruction mediated by cytokines and other molecules. Chondrocyte activity and metabolism have attracted interest as targets of drug intervention, and spa-therapy can influence the serum levels of several cytokines. We investigated the effects of spa-therapy on clinical and ultrasonographic (US) findings and serum levels of cartilage oligomeric matrix protein (COMP) and several cytokines, chemokines, and growth factors in a prospective cohort of patients with symptomatic knee OA. METHODS: Patients (n=53) with primary symptomatic knee OA were treated for 12 consecutive days with locally applied mud-packs. Assessments were made at baseline, immediately after completion of the treatment cycle, and 6 and 12 months after completion of treatment. They included visual analogue scale (VAS) ratings of pain, the Lequesne algofunctional index for knee OA, and US with calculation of a semiquantitative score that expressed the severity of the local inflammatory process. Serum levels of 27 cytokines (including interferon--inducible protein-10 [IP-10]), chemokines, and growth factors were measured with multiplex bead-based immunoassays, and COMP levels were determined by ELISA. RESULTS: US scores, VAS pain ratings, and Lequesne indexes indicated significant improvement after spa-therapy and at the 6- and 12-month follow-ups. Serum IP-10 levels also dropped significantly (p=0.0035), and this reduction was positively correlated with improvement of the Lequesne index (p=0.031). CONCLUSIONS: In patients with knee OA, spa-therapy can modulate serum levels of proinflammatory cytokines/chemokines and produce improvements in joint pain and function that persists for up to 1 year.


Assuntos
Banhos/métodos , Estâncias para Tratamento de Saúde , Peloterapia/métodos , Osteoartrite do Joelho/terapia , Proteína de Matriz Oligomérica de Cartilagem , Estudos de Coortes , Citocinas/sangue , Proteínas da Matriz Extracelular/sangue , Glicoproteínas/sangue , Humanos , Proteínas Matrilinas , Osteoartrite do Joelho/sangue , Osteoartrite do Joelho/diagnóstico por imagem , Medição da Dor , Ultrassonografia
3.
Clin Ter ; 160(2): 115-9, 2009.
Artigo em Italiano | MEDLINE | ID: mdl-19452099

RESUMO

AIMS: Mud-bath treatment has a relevant therapeutic activity in reducing symptoms and disabilities in rheumatic diseases, as studies on inflammation process and clinical symptomatology have shown. Objective of this study is to evaluate the efficacy of mud therapy by natural limans of Cervia on clinical parameters in patients with lumbar spine osteoarthrosis (OA). MATERIALS AND METHODS: 30 patients (20 females and 10 males) suffering from lumbar OA, diagnosed by clinical symptoms and X-Ray findings (osteophytosis, morphological changes of vertrebral somes, tightness of intervertebral spaces, alterated lumbar physiologic lordosis) were studied. All patients were examined first when recruited (T0) and after two weeks of therapy (T1). Interviews were submitted in order to estimate functional restrictions and pain. Statistical analysis was performed via t test for paired data. RESULTS: On the basis of the statistical analysis a very significant difference was demonstrated between the average values of the tests before and after the treatment. These results confirm the improvement of the symptoms concerning the pain, the articular functionality and the quality of life. CONCLUSIONS: The results of the study demonstrate the efficacy of the mud-bath treatment with natural limans of Cervia on the patients affected by lumbar spine osteoarthrosis (OA).


Assuntos
Vértebras Lombares , Peloterapia , Osteoartrite da Coluna Vertebral/terapia , Adulto , Idoso , Balneologia , Feminino , Sedimentos Geológicos/química , Humanos , Itália , Masculino , Pessoa de Meia-Idade , Águas Minerais/análise , Qualidade de Vida , Recuperação de Função Fisiológica , Temperatura
4.
Reumatismo ; 60 Suppl 1: 59-69, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18852909

RESUMO

Fibromyalgia is a complex syndrome associated with significant impairment in quality of life and function and with substantial financial costs. Once the diagnosis is made, providers should aim to increase patients' function and minimize pain. Fibromyalgia patients frequently use alternative therapies, strongly indicating both their dissatisfaction with and the substantial ineffectiveness of traditional medical therapy, especially pharmacological treatments. At present, pharmacological treatments for fibromyalgia have a rather discouraging cost/benefit ratio in terms of poor symptom control and high incidence of side effects. The interdisciplinary treatment programs have been shown to improve subjective pain with greater success than monotherapy. Physical therapies, rehabilitation and alternative therapies are generally perceived to be more "natural," to have fewer adverse effects, and in some way, to be more effective. In this review, physical exercise and multimodal cognitive behavioural therapy are presented as the more accepted and beneficial forms of nonpharmacological therapy.


Assuntos
Fibromialgia/terapia , Terapia Cognitivo-Comportamental , Terapias Complementares , Terapia por Exercício , Humanos , Modalidades de Fisioterapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA